Management of Severe Hyperglycemia with Loss of Appetite

Immediate Assessment and Stabilization

The American Diabetes Association recommends checking for ketones immediately in any patient with glucose >300 mg/dL, as loss of appetite combined with severe hyperglycemia strongly suggests DKA or HHS 1, 2
If ketones are present, suspect early ketoacidosis, call for urgent physician evaluation, and consider ICU transfer—do not delay treatment, as recommended by the American College of Clinical Endocrinologists 1, 2
In type 2 diabetes, loss of appetite with severe hyperglycemia should raise suspicion for hyperosmolar hyperglycemic state, which presents with variable and deceptive symptoms including fatigue, confusion, and dehydration, according to the European Association for the Study of Diabetes 1
Measure serum electrolytes urgently if hyperosmolarity is suspected (>320 mosmol/L confirms diagnosis and mandates ICU-level care), as suggested by the American Association of Clinical Endocrinologists 1

The American College of Clinical Endocrinologists recommends starting rapid-acting insulin analogue immediately at 4-10 units subcutaneously, even before full workup is complete, as delays worsen outcomes 1, 3
Ensure aggressive hydration with IV fluids if the patient cannot maintain oral intake, as dehydration exacerbates hyperglycemia and increases complication risk, according to the American Diabetes Association 1
Monitor capillary blood glucose every 1-2 hours initially to assess response and prevent overcorrection, as recommended by the European Association for the Study of Diabetes 1, 4

For type 1 diabetes or suspected insulin deficiency, initiate basal-bolus insulin immediately with total daily dose of 0.4-0.5 units/kg/day, giving 50% as basal insulin and 50% as prandial insulin divided among meals, as suggested by the International Diabetes Federation 5, 6
For a 50 kg patient, this translates to approximately 10 units of basal insulin once daily plus 6-7 units of rapid-acting insulin divided before meals, according to the American Association of Clinical Endocrinologists 6
Never delay basal insulin even if oral intake is poor—reduce prandial doses but maintain basal coverage to prevent ketosis, as recommended by the American College of Clinical Endocrinologists 1, 5

Ensure adequate fluid and caloric intake through small, frequent meals or liquid nutrition supplements if solid food is not tolerated, as suggested by the European Society for Clinical Nutrition and Metabolism 1, 4
If nausea or vomiting accompanies hyperglycemia, this strongly suggests DKA and requires immediate medical intervention—do not attempt outpatient management, according to the American College of Gastroenterology 4, 7

Increase basal insulin by 4 units every 3 days if fasting glucose remains ≥180 mg/dL, or by 2 units every 3 days if fasting glucose is 140-179 mg/dL, as recommended by the American Diabetes Association 3, 6
Target fasting glucose of 80-130 mg/dL (4.4-7.2 mmol/L) as the primary endpoint for basal insulin titration, according to the European Association for the Study of Diabetes 3, 6
If basal insulin exceeds 0.5 units/kg/day without achieving targets, add or intensify prandial insulin rather than continuing to escalate basal insulin alone, as suggested by the International Diabetes Federation 5, 6

Do not delay insulin initiation while attempting to optimize oral agents—glucose >400 mg/dL with symptoms mandates immediate insulin therapy, according to the American College of Clinical Endocrinologists 3, 5
Do not rely solely on correction insulin (sliding scale) without scheduled basal and prandial insulin, as this leads to persistent hyperglycemia and increased complications, as recommended by the American Diabetes Association 4, 7

Reassess within 24-48 hours if managing as outpatient, or immediately if any signs of DKA/HHS develop, according to the American College of Emergency Physicians 1, 4
Check HbA1c to determine duration of hyperglycemia and guide long-term management strategy, as suggested by the American Association of Clinical Endocrinologists 3, 5